Published in J Urol on July 01, 2003
Urodynamic profile of patients with neurogenic bladder following non-traumatic myelopathies. Ann Indian Acad Neurol (2013) 0.85
Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90
Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol (2007) 6.73
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59
American Urological Association guideline on the management of priapism. J Urol (2003) 3.77
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol (2011) 3.00
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. Mayo Clin Proc (2003) 2.75
Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol (2008) 2.43
Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol Urodyn (2012) 2.35
Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol (2011) 2.09
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol (2012) 1.81
A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol (2009) 1.76
Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med (2008) 1.68
The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. J Urol (2012) 1.64
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn (2012) 1.56
Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure-flow study parameters in clinically obstructed women with those of normal controls. Urology (2004) 1.55
Chapter 1: The management of erectile dysfunction: an AUA update. J Urol (2005) 1.55
Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn (2010) 1.55
The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int (2013) 1.52
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Histologic comparison of pubovaginal sling graft materials: a comparative study. Urology (2008) 1.48
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler (2013) 1.47
Overactive bladder: evaluation and management in primary care. Cleve Clin J Med (2005) 1.45
Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemp Clin Trials (2009) 1.44
A randomized, controlled clinical trial of a novel intravesical pressure attenuation device for the treatment of stress urinary incontinence. J Urol (2013) 1.38
Characteristics of persons with overactive bladder of presumed neurologic origin: results from the Boston Area Community Health (BACH) survey. Neurourol Urodyn (2012) 1.38
Early results of pubovaginal sling lysis by midline sling incision. Urology (2002) 1.37
Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol (2011) 1.35
Benign masses of the female periurethral tissues and anterior vaginal wall. Curr Urol Rep (2008) 1.30
AUA guideline on the pharmacologic management of premature ejaculation. J Urol (2004) 1.28
Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007) 1.25
Porcine dermis interposition graft for repair of high grade anterior compartment defects with or without concomitant pelvic organ prolapse procedures. J Urol (2004) 1.21
Mini-slings can cause complications. Int Urogynecol J (2014) 1.19
Approach to management of iatrogenic foreign bodies of the lower urinary tract following reconstructive pelvic surgery. J Urol (2012) 1.19
Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn (2008) 1.14
Laparoscopic renal parenchymal hypothermia with novel ice-slush deployment mechanism. Urology (2005) 1.13
Alteration in irrigant flow and deflection of flexible ureteroscopes with nitinol baskets. J Endourol (2006) 1.12
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study. J Urol (2009) 1.11
Urodynamic changes associated with successful stress urinary incontinence surgery: is a little tension a good thing? Urology (2011) 1.08
Epidemiology of stress urinary incontinence in women. Curr Urol Rep (2011) 1.02
Fluoroscopy time during uncomplicated unilateral ureteroscopy for urolithiasis decreases with urology resident experience. World J Urol (2014) 1.02
Patterns and predictors of urodynamics use in the United States. J Urol (2012) 1.02
Clarifying the role of urodynamics in the preoperative evaluation of stress urinary incontinence. ScientificWorldJournal (2008) 1.01
Transdermal delivery of drugs for urologic applications: basic principles and applications. Urology (2006) 1.01
Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn (2010) 1.01
Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol (2012) 1.00
Obturator foramen dissection for excision of symptomatic transobturator mesh. J Urol (2012) 0.98
Role of nicotinic and estrogen signaling during experimental acute and chronic bladder inflammation. Am J Pathol (2007) 0.98
Urethral injections for female stress incontinence. BJU Int (2006) 0.97
Histopathological evaluation of the uterosacral ligament: is this a dependable structure for pelvic reconstruction? BJU Int (2006) 0.97
The evaluation and treatment of nocturia: a consensus statement. BJU Int (2011) 0.97
Removal of transobturator midurethral sling for refractory thigh pain. Urology (2008) 0.96
Overactive bladder in the male patient: bladder, outlet, or both? Curr Urol Rep (2002) 0.96
Genitourinary fistula experience in Sierra Leone: review of 505 cases. J Urol (2009) 0.95
The reproducibility of urodynamic findings in healthy female volunteers: results of repeated studies in the same setting and after short-term follow-up. Neurourol Urodyn (2004) 0.95
Sling failures: what's next? Curr Urol Rep (2004) 0.92
Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J Urol (2010) 0.92
The evolution of obstruction induced overactive bladder symptoms following urethrolysis for female bladder outlet obstruction. J Urol (2008) 0.91
Diagnosis and management of outlet obstruction in the female. Curr Opin Urol (2008) 0.91
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol (2009) 0.91
Prospective evaluation of learning curve for laparoscopic radical prostatectomy: identification of factors improving operative times. Urology (2005) 0.90
Encapsulation of a porcine dermis pubovaginal sling. J Urol (2003) 0.90
Effect of 6F urethral catheterization on urinary flow rates during repeated pressure-flow studies in healthy female volunteers. Urology (2002) 0.90
Changes in urodynamic measures two years after Burch colposuspension or autologous sling surgery. Urology (2011) 0.89
Longterm changes in creatinine clearance after laparoscopic renal surgery. J Am Coll Surg (2008) 0.89
Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention? Neurourol Urodyn (2005) 0.89
Urethral distortion after placement of synthetic mid urethral sling. J Urol (2011) 0.88
Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology (2002) 0.87
Biocompatibility assessment of synthetic sling materials for female stress urinary incontinence. J Urol (2007) 0.87
Do the urinary bladder and large bowel interact, in sickness or in health? ICI-RS 2011. Neurourol Urodyn (2012) 0.87
Pharmacologic manipulation of the porcine ureter: Acute impact of topical drugs on ureteral diameter and peristaltic activity. J Endourol (2006) 0.87
Overactive bladder and mixed incontinence. Curr Urol Rep (2010) 0.87
Urodynamic effects of once-daily tadalafil in men with LUTS secondary to clinical BPH. Curr Urol Rep (2010) 0.87
Nicotinic signaling ameliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamide. J Urol (2008) 0.86
Vaginal mesh update. Curr Opin Urol (2012) 0.86
The use of a multidisciplinary morbidity and mortality conference to incorporate ACGME general competencies. J Surg Educ (2011) 0.86
Vesicovaginal fistula following a transobturator midurethral sling procedure. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.86
Management of intrinsic sphincteric deficiency in women. J Urol (2003) 0.85
Pelvic organ prolapse (POP) surgery: the evidence for the repairs. BJU Int (2011) 0.84
Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol (2003) 0.84
Analysis of patient and technical factors associated with midurethral sling mesh exposure and perforation. Int J Urol (2014) 0.83
Reduction of moderate-to-large cystocele during urodynamic evaluation using a vaginal gauze pack: 8-year experience. BJU Int (2006) 0.83
Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studies. J Urol (2005) 0.83
Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology (2003) 0.83
The impact of the overactive bladder syndrome on sexual function: a preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial. Am J Obstet Gynecol (2006) 0.83
Urethral bulking: a urology perspective. Urol Clin North Am (2012) 0.82
Effect of antacid on the pharmacokinetics of extended-release formulations of tolterodine and oxybutynin. Clin Pharmacokinet (2004) 0.82
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol (2005) 0.82
Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol (2009) 0.82
Management of refractory urinary urge incontinence following urogynecological surgery with sacral neuromodulation. Neurourol Urodyn (2007) 0.82
Beyond collagen: injectable therapies for the treatment of female stress urinary incontinence in the new millennium. Urol Clin North Am (2002) 0.81
Defining the role of urodynamics in predicting voiding dysfunction after anti-incontinence surgery: a work in progress. Curr Opin Urol (2010) 0.81
Management of overactive bladder with transdermal oxybutynin. Rev Urol (2006) 0.81
Mixed incontinence and cystocele: postoperative urge symptoms are not predicted by preoperative urodynamics. Int Urogynecol J (2010) 0.81